MARTINGALE ASSET MANAGEMENT L P
Position in PBH — Prestige Consumer Healthcare Inc.
CIK 936944
BOSTON, MA
Position in PBH
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$2,474,111
-$550,970 QoQ
Shares Held
52,340
+2.5% QoQ
Ownership
0.110%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#82
of 318 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 64%
Shared 0%
None 36%
Common Shares in PBH Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026MARTINGALE ASSET MANAGEMENT L P holds $52,615,067 across 17 Drug Manufacturers - Specialty & Generic names. PBH ranks #9 (4.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
69,799 | $11,763,923 | |
| 2 | ALKS |
Alkermes plc.
|
170,004 | $8,908,209 | |
| 3 | AMRX |
Amneal Pharmaceuticals, Inc.
|
283,033 | $4,899,301 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
7,622 | $4,129,828 | |
| 5 | INDV |
Indivior Pharmaceuticals, Inc.
|
85,564 | $3,510,690 | |
| 6 | SUPN |
Supernus Pharmaceuticals, Inc.
|
74,348 | $3,457,925 | |
| 7 | PCRX |
Pacira BioSciences, Inc.
|
112,025 | $2,842,074 | |
| 8 | ANIP |
Ani Pharmaceuticals Inc
|
30,741 | $2,544,739 |
All Filings in PBH
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,474,111 | 52,340 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $3,025,081 | 51,039 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $2,605,168 | 42,230 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $2,317,598 | 37,141 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $2,938,639 | 36,802 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $3,172,464 | 36,902 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $2,887,923 | 36,982 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $2,665,609 | 36,971 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $2,535,814 | 36,831 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $2,672,892 | 36,837 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $2,206,185 | 36,037 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $2,166,928 | 37,890 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $2,269,631 | 38,190 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $2,824,612 | 45,100 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $4,027,997 | 64,345 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $3,205,962 | 64,338 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $3,593,032 | 61,106 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $3,193,605 | 60,325 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $3,780,010 | 62,325 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $3,831,470 | 68,285 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,591,915 | 30,555 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $2,237,280 | 50,755 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $1,745,382 | 50,054 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $5,057,281 | 138,860 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $9,129,258 | 243,058 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $8,911,699 | 242,958 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||